Yeşiltepe Esra, Duman Derya, Kuyucu Necdet, Bozdoğan Sevcan Tuğ, Çıtırık Lara, Yeşil Edanur, Karpuz Derya
Department of Pediatrics, Faculty of Medicine, Mersin University, 33343, Mersin, Turkey.
Department of Pediatric Cardiology, Faculty of Medicine, University of Mersin, 34. Cadde, Ciftlikkoy Kampusu, 33343, Mersin, Turkey.
Indian Pediatr. 2025 May;62(5):372-377. doi: 10.1007/s13312-025-00047-z. Epub 2025 Apr 11.
Fc gamma receptor IIa (FCGR2A) gene polymorphism is associated with increased susceptibility to autoimmune and infectious diseases. The aim of the present study was to evaluate the association of FCGR2A rs1801274 polymorphism with the development and severity of multisystem inflammatory syndrome in children (MIS-C).
This case-control study was conducted in a single center with MIS-C patients and healthy children. Clinical and cardiac imaging data of the participants was collected. The association between the clinical severity of the disease and FCGR2A rs1801274 polymorphism were investigated.
There was no significant association between FCGR2A rs1801274 polymorphism and cardiovascular complications in MIS-C patients. However, those with homozygous FCGR2A rs1801274 gene polymorphism developed severe cardiac dysfunction and required immunomodulatory agents other than intravenous immunoglobulin. The mean age of the patients with severe MIS-C was significantly higher than those with mild MIS-C, and systolic dysfunction was significant.
Further multicenter studies in different ethnic groups are needed to evaluate the association between differences in the FCGR2A rs1801274 gene and severity of MIS-C and/or other inflammatory diseases.
Mersin University Clinical Trial Registry, Decision number 2022/280 dated April 20, 2022.
Fcγ受体IIa(FCGR2A)基因多态性与自身免疫性疾病和感染性疾病易感性增加有关。本研究旨在评估FCGR2A rs1801274多态性与儿童多系统炎症综合征(MIS-C)的发生及严重程度之间的关联。
本病例对照研究在一个中心对MIS-C患者和健康儿童进行。收集参与者的临床和心脏影像学数据。研究疾病临床严重程度与FCGR2A rs1801274多态性之间的关联。
FCGR2A rs1801274多态性与MIS-C患者的心血管并发症之间无显著关联。然而,携带FCGR2A rs1801274基因多态性纯合子的患者出现严重的心功能不全,且除静脉注射免疫球蛋白外还需要免疫调节剂。重度MIS-C患者的平均年龄显著高于轻度MIS-C患者,且存在明显的收缩功能障碍。
需要在不同种族群体中进行进一步的多中心研究,以评估FCGR2A rs1801274基因差异与MIS-C和/或其他炎症性疾病严重程度之间的关联。
梅尔辛大学临床试验注册中心,注册号2022年4月20日第2022/280号。